Profile of endometrial cancer patient at Sanglah Hospital, Denpasar, Bali-Indonesia

I Nyoman Gede Budiana; Ida Bagus Gde Fajar  Manuaba; I Gde Sastra  Winata; Budhi Prasetia Santoso; William Alexander Setiawan

doi:10.3889/oamjms.2023.10797

Authors

I Nyoman Gede Budiana Department of Obstetrics and Gynecology
Ida Bagus Gde Fajar Manuaba Department of Obstetrics and Gynecology, Medical Faculty, Udayana University, Sanglah Hospital, Kuta Selatan, Indonesia
I Gde Sastra Winata Department of Obstetrics and Gynecology, Medical Faculty, Udayana University, Sanglah Hospital, Kuta Selatan, Indonesia
Budhi Prasetia Santoso Department of Obstetrics and Gynecology, Medical Faculty, Udayana University, Sanglah Hospital, Kuta Selatan, Indonesia
William Alexander Setiawan Department of Obstetrics and Gynecology, Medical Faculty, Udayana University, Sanglah Hospital, Kuta Selatan, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2023.10797

Keywords:

Endometrial cancer, Risk factors for endometrial cancer, Treatment of endometrial cancer

Abstract

BACKGROUND: Endometrial cancer is one type of cancer that is often experienced by women, especially in the post-menopausal female population. The incidence of endometrial cancer in developing countries, including Indonesia, is increasing due to the lack of access to early detection and diagnosis of endometrial cancer that requires curettage or biopsy that must be done in a hospital.

AIM: The purpose of this study was to observe various risk factors and characteristics of endometrial cancer patients such as initial complaints, age, parity, family history, body mass index, history of hypertension, history of diabetes mellitus, histological type, degree of differentiation, cancer stage, and treatment.

METHODS: This retrospective and descriptive study was carried out at the obstetrics and gynecology polyclinic and the medical record installation at Sanglah Hospital Denpasar Bali from November 2020 until May 2021. A total of 215 patients with endometrial cancer were enrolled in this study.

RESULTS: A total of 215 endometrial cancer were obtained during this study period. The most common clinical characteristics were vaginal bleeding (91.4%), age range between 51 and 60 years old (42%), multiparity (58%), body mass index overweight (55.9%), history of hypertension 54.2%, no history of diabetes mellitus DM (71.8%), Stage II disease (42.5%), Type I endometrioid 53.2%, and operative management 98.4%.

CONCLUSION: Our descriptive study concluded that most of patients were found in Stage II disease of endometrial cancer.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Endometrial Cancer; 2020. Available from: https://www.cancer.org/cancer/endometrial-cancer/about/what-isiendometrial-cancer.html [Last accessed on 2020 Oct 23].

Key Statistics for Endometrial Cancer; 2020. Available from: https://www.cancer.org/cancer/endometrial-cancer/about/key-statistics.html [Last accessed on 2020 Oct 23].

Endometrial Cancer 2013 Report; 2013. Available from: https://www.aicr.org/assets/docs/pdf/reports/2013-cupeendometrial-cancer.pdf [Last accessed on 2013 Oct 13].

Andarieh MG, Delavar MA, Moslemi D, Esmaeilzadeh S. Risk factors for endometrial cancer: Results from a hospital-based case-control study. Asian Pac J Cancer Prev. 2016;17(10):4791-6. https://doi.org/10.22034/apjcp.2016.17.10.4791 PMid:27910901

Aune D, Sen A, Vatten LJ. Hypertension and the risk of endometrial cancer: A systemic review and meta-analysis of case-control and cohort studies. Sci Rep. 2017;7:44808. https://doi.org/10.1038/srep44808 PMid:28387226 DOI: https://doi.org/10.1038/srep44808

Banno K, Yanokura M, Iida M, Masuda K, Aoki D. Carcinogenic mechanisms of endometrial cancer: Involvement of genetics and epigenetics. J Obstet Gynaecol Res. 2014;40(8):1957-67. https://doi.org/10.1111/jog.12442 PMid:25131761 DOI: https://doi.org/10.1111/jog.12442

Berek JS, Hacker NF. Berek and Hacker Gynecologic Oncology. 6th ed. Philadelphia, PA: Wolters Kluwer; 2015. p. 390-442.

Budiana IN. Peran Spesialis Obstetri dan Ginekologi dalam Penatalaksanaan Kanker Endometrium. Universitas Udayana, Denpasar. Pendidikan Kedokteran Berkelanjutan; 2015. p. 129.

Buhtoiarova TN, Brenner CA, Singh M. Role of current and emerging biomarkers in resolving persistent clinical dilemmas. Am J Pathol. 2016;146(1):8-21. https://doi.org/10.1093/ajcp/aqv014 PMid:26712866 DOI: https://doi.org/10.1093/ajcp/aqv014

Byrne FL, Martin AR, Kosasih M, Caruana BT, Farrell R. The role of hyperglycemia in endometrial cancer pathogenesis. Cancers (Basel). 2020;12(5):1191. https://doi.org/10.3390/cancers12051191 PMid:32397158 DOI: https://doi.org/10.3390/cancers12051191

Centers for Disease Control and Prevention. Leading Cancer Cases and Deaths, All Races/Ethnicitis, Female; 2017. Available from: https://www.gis.cdc.gov/Cancer/USCS/DataViz.html [Last accessed on 2020 Oct 23].

Constantine GD, Kessler G, Graham S, Goldstein SR. Increased incidence of endometrial cancer following the women’s health initiative: An assessment of risk factors. J Womens Health (Larchmt). 2019;28(2):237-44. https://doi.org/10.1089/jwh.2018.6956 PMid:30484734 DOI: https://doi.org/10.1089/jwh.2018.6956

Dewi PP, Budiana IN. Profile of endometrial cancer patients at RSUP Sanglah Denpasar period August 2012-July 2014. E J Medika. 2017;6(8):1-7.

Di Saia PJ, Creasman WT, Mannel RS, McMeekin DS, Mutch DG. Clinical Gynecologic Oncology. 8thed. Philadelphia, PA: Elsevier; 2012. p. 121-40.

Dossus L, Allen N, Kaaks R, Bakken K, Lund E, Tjonneland A, et al. 2010. Reproductive risk factors and endometrial cancer: The European prospective investigation into cancer and nutrition. Int J Cancer. 2010;127(2):442-51. https://doi.org/10.1002/ijc.25050 PMid:19924816 DOI: https://doi.org/10.1002/ijc.25050

Effendi A, Fidiawati WA, Rustam RP. Profile of Cancer Sufferers Endometrium in RSUD Arifin Achmad Pekanbaru Period 2008-2013. Doctoral Dissertation, Indonesia: University Riau; 2014.

Felix AS, Bower JK, Pfeiffer RM, Raman SV, Cohn DE, Sherman ME. High cardiovascular disease mortality after endometrial cancer diagnosis: Results from the surveillance, epidemiology, and end results (SEER) database. Int J Cancer. 2017;140(3):555-64. https://doi.org/10.1002/ijc.30470 PMid:27741565 DOI: https://doi.org/10.1002/ijc.30470

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-86. DOI: https://doi.org/10.1002/ijc.29210

Furness S, Roberts H, Marjoribanks J, Lethaby A, Hickey M, Farquhar C. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Cochrane Database Syst Rev. 2009(2):CD000402. https:/doi.org/10.1002/14651858.CD000402.pub4 DOI: https://doi.org/10.1002/14651858.CD000402.pub3

Hoffman LB, Schorge JO. Williams Gynecology. 4thed. United States: McGraw Hill; 2020. p. 699-721.

Huvila J. Endometrial Carcinoma: Histopathology and Pathogenesis; 2019. p. 1-15. Available from: https://www.uptodate.com/contents/endometrial-carcinoma-histopathologyandpathogenesis?topicref=3249&source=see_link [Last accessed on 2019 May 25].

Iswari WP. Prevalence and Characteristics of Endometrial Tumors at Home Hasan Sadikin Hospital Bandung Period January 2016-December 2016. Indonesia: Doctoral Dissertation, Maranatha Christian University; 2018.

Jung KJ, Park C, Yun YD, Jee SH. Duration of ovarian hormone exposure and gynecological cancer risk in Korean women: The Korean heart study. Cancer Epidemiol. 2016;41:1-7. https://doi.org/10.1016/j.canep.2016.01.005 PMid:26773407 DOI: https://doi.org/10.1016/j.canep.2016.01.005

Kristensen AB, Hare-Bruun H, Høgdall CK, Rudnicki M. Influence of body mass index on tumor pathology and survival in uterine cancer: A Danish register study. Int J Gynecol Cancer. 2017;27(2):281-8. https://doi.org/10.1097/IGC.0000000000000874 PMid:27922975 DOI: https://doi.org/10.1097/IGC.0000000000000874

Lee-May C, Jonathan SB. Endometrial Carcinoma: Epidemiology and Risk Factors; 2019. p. 1-29. Available from: https://www.uptodate.com/contents/endometrialcarcinoma-epidemiology-and-riskfactors?topicref=17006&source=see_link [Last accessed on 2019 May 25].

Leslie KK, Thiel KW, Goodheart MJ, De Geest K, Jia Y, Yang S. Endometrial cancer. Obstet Gynecol Clin North Am. 2012;39(2):255-68. https://doi.org/10.1016/j.ogc.2012.04.001 PMID: 22640714 DOI: https://doi.org/10.1016/j.ogc.2012.04.001

Lortet-Tieulent J, Ferlay J, Bray F, Jemal A. International patterns and trends in endometrial cancer incidence, 1978-2013. J Natl Cancer Inst. 110(4):354-61. https://doi.org/10.1093/jnci/djx214 PMid:29045681 DOI: https://doi.org/10.1093/jnci/djx214

Mourits M, De Vries EG, Willemse PH, Ten Hoor KA, Hollema H, Van der Zee AG. Tamoxifen treatment and gynecologic side effects: A review. Obstet Gynecol. 2001;97(5 Pt 2):855-66. https://doi.org/10.1016/s0029-7844(00)01196-0 PMid:11336777 DOI: https://doi.org/10.1097/00006250-200105000-00055

Mueck AO, Seeger H, Rabe T. Hormonal contraception and risk of endometrial cancer: A systematic review. Endocr Relat Cancer. 2010;17(4):R263-71. https://doi.org/10.1677/ERC-10-0076 PMid:20870686 DOI: https://doi.org/10.1677/ERC-10-0076

Nagle CM, Crosbie EJ, Brand A, Obermair A, Oehler MK, Quinn M, et al. Australian National Endometrial Cancer Study group. The association between diabetes, comorbidities, body mass index and all-cause and cause-specific mortality among women with endometrial cancer. Gynecol Oncol. 2018;150(1):99-105. https://doi.org/10.1016/j.ygyno.2018.04.006 PMid:29706522 DOI: https://doi.org/10.1016/j.ygyno.2018.04.006

Querleu D, Planchamp F. Clinical practice guidelines for the management of patients with endometrial cancer in France: Recommendations of the Institut National du Cancer and the Société Française d’Oncologie Gynécologique. Int J Gynecol Cancer. 2011;21(5):945-50. https: doi.org10.1097/IGC.0b013e31821bd473 PMid:21697683 DOI: https://doi.org/10.1097/IGC.0b013e31821bd473

Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569-78. https://doi.org/10.1016/S0140-6736(08)60269-X PMid:18280327 DOI: https://doi.org/10.1016/S0140-6736(08)60269-X

Schonfeld SJ, Hartge P. Aggregated Analysis of Hormonal Factors and Endometrial Cancer Risk by Parity. France: International Agency for Research on Cancer; 2012. DOI: https://doi.org/10.1002/cncr.27909

Seretis A, Cividini S, Markozannes G, Tseretopoulou X, Lopez DS, Ntzani EE, et al. Association between blood pressure and risk of cancer development: A systematic review and meta-analysis of observational studies. Sci Rep. 2019;9(1):8565. https://doi.org/10.1002/cncr.27909 PMid:31189941 DOI: https://doi.org/10.1038/s41598-019-45014-4

Setiawan VW, Monroe KR, Goodman MT, Colonel LN, Pike MC, Henderson BE. Alcohol consumption and endometrial cancer risk: The multiethnic cohort. Int J Cancer. 2007;122(3):634-8. https://doi.org/10.1002/cncr.27909 PMid:23280123 DOI: https://doi.org/10.1002/ijc.23072

Sofian A, Kampono N, Siregar B. Clinicopathological aspects of cancer patients Endometrium at RSUPNCM in 1994 ± 2003 and the role of Vimentin Immunohistochemistry as a Marker of the Origin of Endometrial Cancer Tissue, Oncology ± Gynecology Subdivision. Indonesia: FK-UI/RSCM; 2005.

Sponholtz TR, Palmer JR, Rosenberg L, Hatch EE, Adams- Campbell LL, Wise LA. Reproductive factors and incidence of endometrial cancer in U.S. Black women. Cancer Causes Control. 2017;28(6):579-88. https://doi.org/10.1007/s10552-017-0880-4 PMid:28361447 DOI: https://doi.org/10.1007/s10552-017-0880-4

Tulumang JA, Loho MF, Mamengko LM. Overview of endometrial cancer who was treated at Prof. Hospital. Dr. RD Kandou Manado period 2013-2015. J E Clinic (eCL). 2016;4(1):1-6. DOI: https://doi.org/10.35790/ecl.4.1.2016.11261

Turati F, Galeone C, Augustin LS, La Vecchia C. Glycemic index, glycemic load and cancer risk: An updated meta-analysis. Nutrients. 2019;11(10):2342. https://doi.org/10.3390/nu11102342 PMid:31581675 DOI: https://doi.org/10.3390/nu11102342

Van Weelden WJ, Fasmer KE, Tangen IL, IntHout J, Abbink K, van Herwaarden AE, et al. Impact of body mass index and fat distribution on sex steroid levels in endometrial carcinoma is a retrospective study. BMC Cancer. 2019;19(1):547. https://doi.org/10.1186/s12885-019-5770-6 PMid:31174495 DOI: https://doi.org/10.1186/s12885-019-5770-6

Wilczynski M, Danielska J, Wilczynski J. An update of the classical Bokhman’s dualistic model of endometrial cancer. Prz Menopauzalny. 2016;15(2):63-8. https://doi.org/10.5114/pm.2016.61186 PMid:27582678 DOI: https://doi.org/10.5114/pm.2016.61186

Win AK, Reece JC, Ryan S. Family history and risk of endometrial cancer. Obstet Gynecol. 2015;125(1):89-98. https://doi.org/10.5114/pm.2016.61186 PMid:25560109 DOI: https://doi.org/10.1097/AOG.0000000000000563

World Health Organization. Cancer Today. The Global Cancer Observatory. Geneva: World Health Organization; 2020. Available from: https://www.gco.iarc.fr/today/home [Last accessed on 2020 Oct 23].

World Health Organization. Cancer Today. International Agency for Research on Cancer. Geneva: World Health Organization; 2020. Available from: https://www.gco.iarc.fr/today/home [Last accessed on 2020 Oct 23].

Wu QJ, Li UU, Tu C, Zhu J, Qian KQ, Feng TB, et al. Parity and endometrial cancer risk: A meta-analysis of epidemiological studies. Sci Rep. 2015;5:14243. https://doi.org/10.1038/srep14243 PMid:26373341 DOI: https://doi.org/10.1038/srep14243

Yang HP, Cook LS, Weiderpass E, Adami HO, Anderson KE, Cai H, et al. Infertility and incident endometrial cancer risk: A pooled analysis from the epidemiology of endometrial cancer consortium (E2C2). Br J Cancer. 2015;112(5):925-33. https://doi.org/10.1038/bjc.2015.24 PMid:25688738 DOI: https://doi.org/10.1038/bjc.2015.24

Yang X, Wang J. The role of metabolic syndrome in endometrial cancer: A review. Front Oncol. 2019;9:744. https://doi.org/10.3389/fonc.2019.00744 PMid:31440472 DOI: https://doi.org/10.3389/fonc.2019.00744